Drug Patent Expirations for the week of February 24, 2013

Tradename	Applicant	Generic Name	Patent No.	Patent Expiration
PREZISTA	Janssen Prods	darunavir ethanolate	6,335,460*PED	Feb 25, 2013
DATSCAN	Ge Hlthcare Inc	ioflupane i-123	5,310,912	Feb 25, 2013
THALOMID	Celgene	thalidomide	7,723,361	Mar 1, 2013
THALOMID	Celgene	thalidomide	6,235,756	Mar 1, 2013
THALOMID	Celgene	thalidomide	8,143,283	Mar 1, 2013
LUNESTA	Sunovion Pharms Inc	eszopiclone	6,864,257*PED	Mar 2, 2013
ZOMETA	Novartis	zoledronic acid	4,939,130*PED	Mar 2, 2013
RECLAST	Novartis	zoledronic acid	4,939,130*PED	Mar 2, 2013
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Andhra Pradesh :PGECET 2013 Notification

Drug Patent Expirations for the week of February 17, 2013

Tradename	Applicant	Generic Name	Patent No.	Patent Expiration
ARRANON	Smithkline Beecham	nelarabine	5,821,236	Feb 20, 2013
ARRANON	Smithkline Beecham	nelarabine	5,492,897	Feb 20, 2013
ARRANON	Smithkline Beecham	nelarabine	5,747,472	Feb 20, 2013
ABRAXANE	Abraxis Bioscience	paclitaxel	6,753,006	Feb 22, 2013
ABRAXANE	Abraxis Bioscience	paclitaxel	6,096,331	Feb 22, 2013
ABRAXANE	Abraxis Bioscience	paclitaxel	5,439,686	Feb 22, 2013
ABRAXANE	Abraxis Bioscience	paclitaxel	6,749,868	Feb 22, 2013
ABRAXANE	Abraxis Bioscience	paclitaxel	6,537,579	Feb 22, 2013
ABRAXANE	Abraxis Bioscience	paclitaxel	6,506,405	Feb 22, 2013
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Drug Patent Expirations for the week of February 17, 2013

Tradename	Applicant	Generic Name	Patent No.	Patent Expiration
ARRANON	Smithkline Beecham	nelarabine	5,821,236	Feb 20, 2013
ARRANON	Smithkline Beecham	nelarabine	5,492,897	Feb 20, 2013
ARRANON	Smithkline Beecham	nelarabine	5,747,472	Feb 20, 2013
ABRAXANE	Abraxis Bioscience	paclitaxel	6,753,006	Feb 22, 2013
ABRAXANE	Abraxis Bioscience	paclitaxel	6,096,331	Feb 22, 2013
ABRAXANE	Abraxis Bioscience	paclitaxel	5,439,686	Feb 22, 2013
ABRAXANE	Abraxis Bioscience	paclitaxel	6,749,868	Feb 22, 2013
ABRAXANE	Abraxis Bioscience	paclitaxel	6,537,579	Feb 22, 2013
ABRAXANE	Abraxis Bioscience	paclitaxel	6,506,405	Feb 22, 2013
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Drug Patent Expirations for the week of February 10, 2013

Tradename	Applicant	Generic Name	Patent No.	Patent Expiration
COLESTID	Pharmacia And Upjohn	colestipol hydrochloride	5,490,987	Feb 13, 2013
ZOLOFT	Pfizer	sertraline hydrochloride	5,248,699*PED	Feb 13, 2013
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Drug Patent Expirations for the week of February 3, 2013

Tradename	Applicant	Generic Name	Patent No.	Patent Expiration
IMODIUM MULTI-SYMPTOM RELIEF	Mcneil	loperamide hydrochloride; simethicone	5,489,436	Feb 6, 2013
IMODIUM A-D EZ CHEWS	Mcneil	loperamide hydrochloride	5,489,436	Feb 6, 2013
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Drug Patent Expirations for the week of January 20 & 27, 2013

Drug Patent Expirations for the week of January 20, 2013

Tradename	Applicant	Generic Name	Patent No.	Patent Expiration
MERIDIA	Abbott	sibutramine hydrochloride	5,436,272*PED	Jan 25, 2013
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Drug Patent Expirations for the week of January 27, 2013

Tradename	Applicant	Generic Name	Patent No.	Patent Expiration
STARLIX	Novartis	nateglinide	5,488,150	Jan 30, 2013
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.